Objectives: To develop a standard reference broth microdilution method for antimicrobial susceptibility testing (AST) of Arcobacter butzleri. The protocol was subsequently applied to a collection of A. butzleri isolates from different sources.
Introduction
The aerotolerant Arcobacter butzleri was first described as Campylobacter butzleri in 1991 and was assigned to the genus Arcobacter in 1992. 1, 2 It was initially isolated from diarrhoeal illness in humans, swine and cattle, but has also been associated with abortion in pigs and mastitis in cows. [1] [2] [3] [4] A. butzleri is frequently isolated from water and food, e.g. meat. [5] [6] [7] [8] In recent years, it has also been found in wild animals, as well as in companion animals, such as cats and dogs. [9] [10] [11] Although A. butzleri causes mainly mild gastrointestinal symptoms in humans, 12 it was responsible for an outbreak of recurrent abdominal cramps in an Italian school. 13 Antimicrobial agents are rarely needed for the treatment of A. butzleri infections, as most infections are self-limiting. 12 However, in prolonged or severe cases of the disease, treatment with tetracyclines, aminoglycosides or fluoroquinolones is recommended.
14 Antimicrobial susceptibility testing (AST) of A. butzleri is problematic as there is no standardized AST method available to date. Especially in the broth microdilution protocols used so far, considerable variations have been detected, which make it almost impossible to compare the results of previously published studies. 1, [14] [15] [16] Since A. butzleri is reported as an emerging and underestimated pathogen, 17 there is a need for a standardized AST method for this organism.
In the present study, we developed a standardized protocol for AST by broth microdilution of A. butzleri. The protocol was approved by the Veterinary Antimicrobial Susceptibility Testing (VAST) subcommittee of the CLSI in June 2015 and then applied to a collection of 65 German A. butzleri strains from humans and animals, as well as water and meat, in order to test the protocol for its general applicability to A. butzleri from different origins.
Materials and methods

Bacterial isolates
For the development of a standardized broth microdilution method, the two A. butzleri reference strains ATCC V R 49616, isolated in 1991 from a human diarrhoeic stool sample in the USA, and DSM 7301, isolated also in 1991 from a human blood sample in the UK, and six A. butzleri field isolates (three of chicken origin and three of human origin, isolated between 1994 and 2009) were included. Escherichia coli ATCC V R 25922 served as a quality control (QC) strain in AST. The field isolates for the testing of the general applicability of the new protocol comprised a total of 65 A. butzleri collected between 1994 and 2012 in Germany. The vast majority of isolates (53/65) were obtained from meat and meat products: chicken meat (n " 41), pork (n " 7), ground pork/beef (n " 3) and catfish (n " 2). Five isolates originated from human stool samples, four from water samples and three from preputial washings of bulls. The species assignment of all isolates was confirmed by the results of a multiplex PCR. 18 Development of a standardized method for susceptibility testing of A. butzleri
The document VET01-A4 of the CLSI states that the inoculum for broth microdilution tests should be prepared using a bacterial suspension that corresponds in its turbidity to that of a 0.5 McFarland standard (which contains about 1-2%10 8 cfu/mL for most bacterial species). This suspension will then be diluted, so that it results in a final inoculum of approximately 5%10 5 cfu/mL. 19 Plate count assays were conducted with the six A. butzleri field isolates and the two A. butzleri reference strains ATCC V R 49616 and DSM 7301 to determine the volume of the 0.5 McFarland standard suspension to be used for the inoculum preparation in the test medium to yield 2-8%10 5 cfu/mL.
Since A. butzleri showed only poor growth in CAMHB and the supplementation of CAMHB with 2% lysed horse blood did not yield readable MIC values, we tried to find a more suitable medium for broth microdilution AST of A. butzleri. For this, repeated AST of the six epidemiologically unrelated A. butzleri field isolates used for the plate count assays and the two A. butzleri reference strains ATCC V R 49616 and DSM 7301 was performed with the three media CAMHB, CAMHB!2% (v/v) FBS and CAMHB!5% (v/v) FBS, the last being routinely used after in-house validation for
Campylobacter species (K. Stingl, B. Schwarz, P. Vogt and U. Lenski, unpublished data). The microtitre plates were incubated at 35+2 C in ambient air. We did not notice relevant differences in growth characteristics when incubating A. butzleri isolates under aerobic and microaerobic conditions (data not shown). The microtitre plates were read visually after 24 and 48 h, and the AST was performed five times on independent occasions.
The results of the comparative testing of the three media and the eight A. butzleri isolates were statistically analysed to detect which combination of medium and incubation time resulted in the most homogeneous MIC values. Homogeneity of MIC values was defined in two different scenarios: (i) all five MIC values for a medium/incubation time combination for a specific antimicrobial agent and bacterial strain have to be identical; and (ii) MIC values are allowed to differ with a maximum variation of +1 dilution step.
Statistical analyses followed the procedures previously used for the establishment of a new AST method for Rhodococcus equi. 20 The odds of homogeneity were modelled with a multiple logistic regression analysis, which included the fixed factors medium/incubation time, antimicrobial agents tested and bacterial isolates. To account for the association of individual MIC values within the two timepoints, the factor combination of medium, antibiotic agent and bacterial strain was added as a random effect. 21 The investigation of interactions was omitted to avoid a limitation of usability. In addition to the global tests, all pairwise comparisons for the levels of medium/incubation time were tested and 95% CIs were estimated. The type I error was set to 5% (two-sided; Table 1 ). For all analyses the SAS System, Version 9.3, was used. 22 
Influence of FBS on MIC values
To determine the influence of FBS on the MIC values, a comparative broth microdilution AST with FBS from three different suppliers (Biochrom, Berlin, Germany; PAN-biotech, Aidenbach, Germany; Gibco, Thermo Fisher, Braunschweig, Germany) was performed. For these tests, the six A. butzleri field strains and the two A. butzleri reference strains ATCC V R 49616 and DSM 7301 were tested in broth microdilution assays with CAMHB!5% FBS at 35+2 C in ambient air and reading of the plates after 24 h. As FBS is not a CLSI-approved supplement for AST, we also tested the influence of FBS on the MIC values for the QC strain E. coli ATCC V R 25922 in order to prove that FBS does not have an impact on the activity of the antimicrobial agents.
Susceptibility testing of field isolates
All A. butzleri isolates from the collection were tested for their susceptibility to 31 antimicrobial agents. For MIC testing, four custom-made microtitre plates Bold formatting indicates the medium/incubation time combination that yielded the highest percentage of homogeneous AST results in both scenarios.
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(Sensititre V R , TREK Diagnostic Systems Inc., Swalmen, The Netherlands) were used. Susceptibility testing was performed using CAMHB!5% FBS, incubated at 35+2 C in ambient air for 24 h. The inoculum was prepared from fresh cultures on blood agar that were incubated aerobically at 35+2 C for 24 h. E. coli ATCC V R 25922 served as a QC strain.
Results and discussion
For inoculum preparation, a volume of 20 lL of an A. butzleri suspension equivalent to a 0.5 McFarland standard per 10 mL of test medium resulted in 2-8%10 5 cfu/mL. Fifty microlitres of this suspension was inoculated in each well of the microtitre plates. As the growth was weak in CAMHB, we tried to find a test medium that enabled improved growth of A. butzleri. The comparative testing of the three media, CAMHB, CAMHB!2% FBS and CAMHB!5% FBS, respectively, resulted in data for six medium/incubation time (24 and 48 h) combinations, 31 antimicrobial agents and eight bacterial isolates. Thus, for each medium/incubation time combination, 248 data points were available.
In scenario (i), for which we assumed identical MIC values in all repetitions, the homogeneity of measurements varied between 13.71% for CAMHB after 24 h and 22.98% for CAMHB!5% FBS after 24 h (Table 1 ). In the multiple logistic regression model differences among antimicrobial agents (P , 0.0001), A. butzleri strains (P , 0.0001) and media/incubation times (P " 0.0197) were found. A difference in the MICs of +1 dilution step is a mistake inherent to Antimicrobial susceptibility of A. butzleri JAC the testing system and therefore widely accepted. Consistently, scenario (ii) exhibited higher percentages of homogeneous MICs, which varied between 42.34% for CAMHB after 24 h and 71.37% for CAMHB!5% FBS after 24 h (Table 1 ). In the multiple logistic regression analysis, again differences among the antibiotic agents (P , 0.0001), A. butzleri strains (P , 0.0001) and media/incubation times (P , 0.0001) were detected. CAMHB!5% FBS and 24 h yielded more homogeneous MIC results than all other medium/incubation time combinations (Table 1) . Information on all pairwise comparisons is provided in Table S1 (available as Supplementary data at JAC Online). Statistical analysis of the data obtained in both scenarios confirmed that the use of CAMHB!5% FBS and reading of the results after 24 h yielded the most homogeneous MIC results. It also turned out that FBS from different suppliers had no influence on MIC values or their readability (Table S2 ). In addition, the QC values of E. coli ATCC V R 25922 were not influenced by the addition of FBS.
The testing of the collection of 65 A. butzleri field isolates revealed that all field isolates could be tested without difficulties and that the MIC values of most antimicrobial agents were distributed unimodally ( Figure 1 . Comparison of the MIC distribution of six antimicrobial agents for the EUCAST datasets on C. jejuni (blue) and C. coli (green), 24 A. butzleri from this study (red) and A. butzleri from the dataset of Van den Abeele et al. 23 (orange) (values .MIC were included as 2%MIC). ECOFFs for C. coli (green broken line) and for C. jejuni (blue broken line) appear on the right-hand side of the respective MIC value. A green and blue broken line illustrates equal ECOFFs for C. coli and C. jejuni.
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preputial washing of a bull. Reduced susceptibility of A. butzleri to the therapeutically relevant drugs tetracycline and gentamicin has only rarely been described. 23 Data on antimicrobial resistance of A. butzleri are sparse due to missing standardized protocols and missing clinical breakpoints, as well as epidemiological cut-off values (ECOFFs); the last two are urgently needed to better classify the MIC results. Nevertheless, we compared our set of data on A. butzleri field isolates, primarily obtained from chicken meat, with recently published MIC data for A. butzleri isolated from humans in Belgium obtained by gradient strip diffusion. 23 Six of the 31 tested antimicrobial agents or agent combinations were also tested in the latter study and, thus, are suitable for comparison (Figure 1) . Additionally, we added the EUCAST MIC distributions 24 available for Campylobacter jejuni and Campylobacter coli (Figure 1) .
For the interpretation of the data on the 63 tested A. butzleri, the authors of the Belgian study used EUCAST breakpoints for C. coli (erythromycin, ciprofloxacin, tetracycline and doxycycline), but also those for Enterobacteriaceae (gentamicin) or nonspecies-related breakpoints for ampicillin. 23 As visualized in Figure 1 , MIC distributions of all four datasets appear to be similar for ciprofloxacin and gentamicin, suggesting the applicability of Campylobacter ECOFFs for A. butzleri. However, all A. butzleri isolates in our study had low MIC values of ciprofloxacin and, consequently, were classified as WT (i.e. they harbour no acquired resistance properties). For doxycycline and tetracycline, the bimodal distribution of the two Campylobacter spp. is not reflected in the A. butzleri datasets from both our study and the study from Belgium, 23 indicating that ECOFFs of Campylobacter might not always be suitable.
When comparing the shape of the MIC frequency distributions, the two datasets on A. butzleri for tetracycline and ampicillin appear to match rather well. However, for erythromycin and doxycycline the isolates tested in our study displayed lower MIC values than the isolates from Belgium. Whether the observed differences were caused by the different methods applied and/or due to the different isolates tested remains to be determined. Hence, data on MIC distributions for A. butzleri that have better comparability are needed. The AST protocol established in this study provides the basis for the reliable and harmonized determination of such MIC values.
